ArticleScience China. Life sciences2017
The triphibious warfare against viruses.
Article in Science China. Life sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Biosafety and immunology: An interdisciplinary field for health priority.Biosafety and health · 2024Review
- Back to Science in Searching for SARS-CoV-2 Origins.China CDC weekly · 2023Article
- Metagenomic analysis of viromes in tissues of wild Qinghai vole from the eastern Tibetan Plateau.Scientific reports · 2022Article
- The Arms Race in the War Between Virus and Host: Implications for Anti-Infection Immunity.Infectious diseases & immunity · 2022Article
- Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.Frontiers of medicine · 2021Review
- Genomic epidemiological characteristics of dengue fever in Guangdong province, China from 2013 to 2017.PLoS neglected tropical diseases · 2020Article
- Laboratory biosafety in China: past, present, and future.Biosafety and health · 2019Article
- Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.PLoS biology · 2019Article
- Nanopore sequencing: a rapid solution for infectious disease epidemics.Science China. Life sciences · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.